Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 135

1.

The role of adipokines in the rapid antidepressant effects of ketamine.

Machado-Vieira R, Gold PW, Luckenbaugh DA, Ballard ED, Richards EM, Henter ID, De Sousa RT, Niciu MJ, Yuan P, Zarate CA Jr.

Mol Psychiatry. 2016 Apr 5. doi: 10.1038/mp.2016.36. [Epub ahead of print]

PMID:
27046644
2.

Evidence for increased motor cortical facilitation and decreased inhibition in atypical depression.

Veronezi BP, Moffa AH, Carvalho AF, Galhardoni R, Simis M, Benseñor IM, Lotufo PA, Machado-Vieira R, Daskalakis ZJ, Brunoni AR.

Acta Psychiatr Scand. 2016 Mar 29. doi: 10.1111/acps.12565. [Epub ahead of print]

PMID:
27028276
3.

THERAPEUTIC MODULATION OF GLUTAMATE RECEPTORS IN MAJOR DEPRESSIVE DISORDER.

Jaso BA, Niciu MJ, Iadarola ND, Lally N, Richards EM, Park M, Ballard ED, Nugent AC, Machado-Vieira R, Zarate CA Jr.

Curr Neuropharmacol. 2016 Mar 21. [Epub ahead of print]

PMID:
26997505
4.

Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.

Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZ, Stella F, Machado-Vieira R, Gattaz WF.

Bipolar Disord. 2016 Feb;18(1):63-70. doi: 10.1111/bdi.12360. Epub 2016 Feb 15.

PMID:
26876913
5.

An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.

Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA Jr.

J Affect Disord. 2016 Apr;194:115-9. doi: 10.1016/j.jad.2016.01.009. Epub 2016 Jan 19.

PMID:
26807672
6.

Quantifying the influence of child abuse history on the cardinal symptoms of fibromyalgia.

Ortiz R, Ballard ED, Machado-Vieira R, Saligan LN, Walitt B.

Clin Exp Rheumatol. 2016 Jan 8. [Epub ahead of print]

PMID:
26743156
7.

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

Richards EM, Mathews DC, Luckenbaugh DA, Ionescu DF, Machado-Vieira R, Niciu MJ, Duncan WC, Nolan NM, Franco-Chaves JA, Hudzik T, Maciag C, Li S, Cross A, Smith MA, Zarate CA Jr.

Psychopharmacology (Berl). 2016 Mar;233(6):1119-30. doi: 10.1007/s00213-015-4195-4. Epub 2016 Jan 4.

PMID:
26728893
8.

New targets for rapid antidepressant action.

Machado-Vieira R, Henter ID, Zarate CA Jr.

Prog Neurobiol. 2015 Dec 23. pii: S0301-0082(15)30038-1. doi: 10.1016/j.pneurobio.2015.12.001. [Epub ahead of print] Review.

PMID:
26724279
9.

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.

Fernandes BS, Molendijk ML, Köhler CA, Soares JC, Leite CM, Machado-Vieira R, Ribeiro TL, Silva JC, Sales PM, Quevedo J, Oertel-Knöchel V, Vieta E, González-Pinto A, Berk M, Carvalho AF.

BMC Med. 2015 Nov 30;13:289. doi: 10.1186/s12916-015-0529-7.

10.

A Selective Association between Central and Peripheral Lithium Levels in Remitters in Bipolar Depression: A 3T-(7) Li Magnetic Resonance Spectroscopy Study.

Machado-Vieira R, Otaduy MC, Zanetti MV, De Sousa RT, Dias VV, Leite CC, Forlenza OV, Busatto GF, Soares JC, Gattaz WF.

Acta Psychiatr Scand. 2016 Mar;133(3):214-20. doi: 10.1111/acps.12511. Epub 2015 Oct 29.

PMID:
26513535
11.

Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.

Soeiro-de-Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa Leite C, Vallada H, Otaduy MC.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2221-9. doi: 10.1016/j.euroneuro.2015.09.020. Epub 2015 Oct 9.

PMID:
26476706
12.

Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics.

de Sousa RT, Zanetti MV, Brunoni AR, Machado-Vieira R.

Curr Neuropharmacol. 2015;13(5):616-35.

13.

A Longitudinal (6-week) 3T (1)H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression.

Machado-Vieira R, Gattaz WF, Zanetti MV, De Sousa RT, Carvalho AF, Soeiro-de-Souza MG, Leite CC, Otaduy MC.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2311-7. doi: 10.1016/j.euroneuro.2015.08.023. Epub 2015 Sep 25.

PMID:
26428274
14.

Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder.

de Sousa RT, Streck EL, Forlenza OV, Brunoni AR, Zanetti MV, Ferreira GK, Diniz BS, Portela LV, Carvalho AF, Zarate CA Jr, Gattaz WF, Machado-Vieira R.

Neurosci Lett. 2015 Sep 25;605:65-8. doi: 10.1016/j.neulet.2015.08.022. Epub 2015 Aug 20.

PMID:
26297865
15.

Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial.

Brunoni AR, Machado-Vieira R, Sampaio-Junior B, Vieira EL, Valiengo L, Benseñor IM, Lotufo PA, Carvalho AF, Cho HJ, Gattaz WF, Teixeira AL.

J Affect Disord. 2015 Oct 1;185:209-13. doi: 10.1016/j.jad.2015.07.006. Epub 2015 Jul 29.

PMID:
26241865
16.

Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders.

Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA Jr.

J Psychiatr Res. 2015 Sep;68:99-105. doi: 10.1016/j.jpsychires.2015.06.012. Epub 2015 Jun 24.

PMID:
26228407
17.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.

Xu AJ, Niciu MJ, Lundin NB, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Machado-Vieira R, Zarate CA Jr.

Neural Plast. 2015;2015:858251. doi: 10.1155/2015/858251. Epub 2015 Jun 7.

18.

Translational Research in Bipolar Disorders.

Machado-Vieira R, Frey BN, Andreazza AC, Quevedo J.

Neural Plast. 2015;2015:576978. doi: 10.1155/2015/576978. Epub 2015 Jun 14. No abstract available.

19.

Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype.

Zimmer ER, Torrez VR, Kalinine E, Augustin MC, Zenki KC, Almeida RF, Hansel G, Muller AP, Souza DO, Machado-Vieira R, Portela LV.

Front Cell Neurosci. 2015 Jun 3;9:219. doi: 10.3389/fncel.2015.00219. eCollection 2015.

20.

Potential Pathways Involved in the Rapid Antidepressant Effects of Nitrous Oxide.

Zarate CA Jr, Machado-Vieira R.

Biol Psychiatry. 2015 Jul 1;78(1):2-4. doi: 10.1016/j.biopsych.2015.04.007. No abstract available.

PMID:
26051637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk